33 KiB
33 KiB
| 1 | Disclaimer: The information presented in On-Screen Results is not intended to be a replacement of the official Lab Results, Alerts, Data Revisions and Cancellations found in the Lab Reports section of this software application. On-Screen Results should not be used for patient diagnosis, treatment decisions or submission to regulatory bodies. | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 | Subject | Subject Data Revision | Screen No. | Age | Age Unit | Gender | Visit | Visit Data Revision | Collected Time | Accession | Test Group | Test | Administrative Question | Value | Result Data Revision | Flags | Cancellation Reason | Comments | Range | Units |
| 3 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | ALP<2XULN | ALP<2XULN | Criteria Met | ||||||||||||
| 4 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | ALT>/=3XULN | ALT >/= 3 X ULN | Criteria not met | ||||||||||||
| 5 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | ALT>/=3XULN & TBIL>/=2XULN | ALT >/=3xULN & TBIL >/=2xULN | Criteria not met | ||||||||||||
| 6 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | AST>/=3XULN | AST >/= 3 X ULN | Criteria not met | ||||||||||||
| 7 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | AST>/=3XULN & TBIL>/=2XULN | AST >/=3xULN & TBIL >/=2xULN | Criteria not met | ||||||||||||
| 8 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | CHEMISTRY PANEL | Total Bilirubin | 6 | 3 - 21 | umol/L | ||||||||||
| 9 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 2.3 | 0 - 6.2 | umol/L | ||||||||||
| 10 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | CHEMISTRY PANEL | Alkaline Phosphatase | 82 | 35 - 104 | U/L | ||||||||||
| 11 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | CHEMISTRY PANEL | ALT (SGPT) | 18 | 4 - 43 | U/L | ||||||||||
| 12 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | CHEMISTRY PANEL | AST (SGOT) | 17 | 8 - 40 | U/L | ||||||||||
| 13 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | CHEMISTRY PANEL | GGT | 11 | 4 - 49 | U/L | ||||||||||
| 14 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | CHEMISTRY PANEL | LDH | 151 | 53 - 234 | U/L | ||||||||||
| 15 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | CHEMISTRY PANEL | Urea Nitrogen | 2.1 | 1.4 - 8.6 | mmol/L | ||||||||||
| 16 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 55 | 31 - 101 | umol/L | ||||||||||
| 17 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | CHEMISTRY PANEL | Serum Glucose | 4.8 | 3.9 - 5.6 | mmol/L | ||||||||||
| 18 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | CHEMISTRY PANEL | Serum Uric Acid | 277 | 125 - 428 | umol/L | ||||||||||
| 19 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | CHEMISTRY PANEL | Calcium (EDTA) | 2.54 | 2.07 - 2.64 | mmol/L | ||||||||||
| 20 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | CHEMISTRY PANEL | Phosphorus | 0.81 | 0.71 - 1.65 | mmol/L | ||||||||||
| 21 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | CHEMISTRY PANEL | Total Protein | 84 | 61 - 84 | g/L | ||||||||||
| 22 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | CHEMISTRY PANEL | Albumin-BCG | 51 | H | 33 - 49 | g/L | |||||||||
| 23 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | CHEMISTRY PANEL | Creatine Kinase | 55 | 26 - 192 | U/L | ||||||||||
| 24 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | CHEMISTRY PANEL | Serum Sodium | 140 | 132 - 147 | mmol/L | ||||||||||
| 25 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | CHEMISTRY PANEL | Serum Potassium | 4.2 | 3.5 - 5.2 | mmol/L | ||||||||||
| 26 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | CHEMISTRY PANEL | Serum Bicarbonate | 23.5 | 19.3 - 29.3 | mmol/L | ||||||||||
| 27 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | CHEMISTRY PANEL | Serum Chloride | 101 | 94 - 112 | mmol/L | ||||||||||
| 28 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | CHEMISTRY PANEL | Magnesium | 0.89 | 0.66 - 1.07 | mmol/L | ||||||||||
| 29 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | CKD-EPI 2021 WITH ADOLESCENTS | CKD-EPI 2021 woRace wAdol -PS | 129 | mL/min/1.73m^2$No Ref Rng | |||||||||||
| 30 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | FECAL COLLECTION D/T | Stool Collection Date | Y | ||||||||||||
| 31 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | FECAL COLLECTION D/T | Stool Collection Time | Y | ||||||||||||
| 32 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 127 | Result verified by repeat analysis | 116 - 164 | g/L | |||||||||
| 33 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.39 | 0.34 - 0.48 | |||||||||||
| 34 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.7 | Result verified by repeat analysis | 4.1 - 5.6 | TI/L | |||||||||
| 35 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 27 | Result verified by repeat analysis | 26 - 34 | pg | |||||||||
| 36 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | Anisocytosis | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 37 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 83 | Result verified by repeat analysis | 79 - 98 | fL | |||||||||
| 38 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 4.41 | Result verified by repeat analysis | 3.8 - 10.7 | GI/L | |||||||||
| 39 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 2.73 | 1.96 - 7.23 | GI/L | ||||||||||
| 40 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.41 | 0.91 - 4.28 | GI/L | ||||||||||
| 41 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.22 | 0.12 - 0.92 | GI/L | ||||||||||
| 42 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.04 | 0 - 0.57 | GI/L | ||||||||||
| 43 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.00 | 0 - 0.2 | GI/L | ||||||||||
| 44 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 62.0 | 40.5 - 75 | % | ||||||||||
| 45 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 32.0 | 15.4 - 48.5 | % | ||||||||||
| 46 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 5.0 | 2.6 - 10.1 | % | ||||||||||
| 47 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 1.0 | 0 - 6.8 | % | ||||||||||
| 48 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.0 | 0 - 2 | % | ||||||||||
| 49 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 340 | Result verified by repeat analysis | 140 - 400 | GI/L | |||||||||
| 50 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | PA1 EEA-2? | Approved to use EEA-2? | Yes | ||||||||||||
| 51 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | SM01/PLASMA PK TROUGH COLL D/T | Collection Date Predose | Y | 07-May-2026 | |||||||||||
| 52 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | SM01/PLASMA PK TROUGH COLL D/T | Collection Time Predose | Y | 12:40 | |||||||||||
| 53 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | SM02/PLASMA PK PEAK COLL D/T | Collection Date Post dose | Y | 07-May-2026 | |||||||||||
| 54 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | SM02/PLASMA PK PEAK COLL D/T | Post Dose Collection Time | Y | 14:20 | |||||||||||
| 55 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | SM04/SERUM ADA PRE COLL D/T | Collection Date Predose | Y | 07-May-2026 | |||||||||||
| 56 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | SM04/SERUM ADA PRE COLL D/T | Collection Time Predose | Y | 12:40 | |||||||||||
| 57 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | SM09/STOOL PK COLL D/T | Stool Collection Date | Y | ||||||||||||
| 58 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | SM09/STOOL PK COLL D/T | Stool Collection Time | Y | ||||||||||||
| 59 | CZ100122001 | Female | Induction Week 4 | May 7, 2026 12:40 PM | 6227697723 | SUBJECT HEIGHT (CM) | Height (cm) | Y | N/A (subject >/= 18 years of age) | cm | ||||||||||
| 60 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | ALP<2XULN | ALP<2XULN | Criteria Met | ||||||||||||
| 61 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | ALT>/=3XULN | ALT >/= 3 X ULN | Criteria not met | ||||||||||||
| 62 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | ALT>/=3XULN & TBIL>/=2XULN | ALT >/=3xULN & TBIL >/=2xULN | Criteria not met | ||||||||||||
| 63 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | AST>/=3XULN | AST >/= 3 X ULN | Criteria not met | ||||||||||||
| 64 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | AST>/=3XULN & TBIL>/=2XULN | AST >/=3xULN & TBIL >/=2xULN | Criteria not met | ||||||||||||
| 65 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | CHEMISTRY PANEL | Total Bilirubin | 4 | 3 - 21 | umol/L | ||||||||||
| 66 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 1.7 | 0 - 6.2 | umol/L | ||||||||||
| 67 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | CHEMISTRY PANEL | Alkaline Phosphatase | 71 | 35 - 104 | U/L | ||||||||||
| 68 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | CHEMISTRY PANEL | ALT (SGPT) | 24 | 4 - 43 | U/L | ||||||||||
| 69 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | CHEMISTRY PANEL | AST (SGOT) | 19 | 8 - 40 | U/L | ||||||||||
| 70 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | CHEMISTRY PANEL | GGT | 12 | 4 - 49 | U/L | ||||||||||
| 71 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | CHEMISTRY PANEL | LDH | 138 | 53 - 234 | U/L | ||||||||||
| 72 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | CHEMISTRY PANEL | Urea Nitrogen | 3.5 | 1.4 - 8.6 | mmol/L | ||||||||||
| 73 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 56 | 31 - 101 | umol/L | ||||||||||
| 74 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | CHEMISTRY PANEL | Serum Glucose | 5.1 | 3.9 - 5.6 | mmol/L | ||||||||||
| 75 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | CHEMISTRY PANEL | Serum Uric Acid | 296 | 125 - 428 | umol/L | ||||||||||
| 76 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | CHEMISTRY PANEL | Calcium (EDTA) | 2.55 | 2.07 - 2.64 | mmol/L | ||||||||||
| 77 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | CHEMISTRY PANEL | Phosphorus | 0.77 | 0.71 - 1.65 | mmol/L | ||||||||||
| 78 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | CHEMISTRY PANEL | Total Protein | 77 | 61 - 84 | g/L | ||||||||||
| 79 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | CHEMISTRY PANEL | Albumin-BCG | 46 | 33 - 49 | g/L | ||||||||||
| 80 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | CHEMISTRY PANEL | Creatine Kinase | 49 | 26 - 192 | U/L | ||||||||||
| 81 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | CHEMISTRY PANEL | Serum Sodium | 138 | 132 - 147 | mmol/L | ||||||||||
| 82 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | CHEMISTRY PANEL | Serum Potassium | 4.3 | 3.5 - 5.2 | mmol/L | ||||||||||
| 83 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | CHEMISTRY PANEL | Serum Bicarbonate | 25.3 | 19.3 - 29.3 | mmol/L | ||||||||||
| 84 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | CHEMISTRY PANEL | Serum Chloride | 100 | 94 - 112 | mmol/L | ||||||||||
| 85 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | CHEMISTRY PANEL | Magnesium | 0.83 | 0.66 - 1.07 | mmol/L | ||||||||||
| 86 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | CKD-EPI 2021 WITH ADOLESCENTS | CKD-EPI 2021 woRace wAdol -PS | 129 | mL/min/1.73m^2$No Ref Rng | |||||||||||
| 87 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | FECAL COLLECTION D/T | Stool Collection Date | Y | 22-Apr-2026 | |||||||||||
| 88 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | FECAL COLLECTION D/T | Stool Collection Time | Y | 05:30 | |||||||||||
| 89 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 128 | Result verified by repeat analysis | 116 - 164 | g/L | |||||||||
| 90 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.40 | Result verified by repeat analysis | 0.34 - 0.48 | ||||||||||
| 91 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.9 | Result verified by repeat analysis | 4.1 - 5.6 | TI/L | |||||||||
| 92 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 26 | Result verified by repeat analysis | 26 - 34 | pg | |||||||||
| 93 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 94 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 81 | Result verified by repeat analysis | 79 - 98 | fL | |||||||||
| 95 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 6.60 | Result verified by repeat analysis | 3.8 - 10.7 | GI/L | |||||||||
| 96 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 4.39 | 1.96 - 7.23 | GI/L | ||||||||||
| 97 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.54 | 0.91 - 4.28 | GI/L | ||||||||||
| 98 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.47 | Result verified by repeat analysis | 0.12 - 0.92 | GI/L | |||||||||
| 99 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.12 | Result verified by repeat analysis | 0 - 0.57 | GI/L | |||||||||
| 100 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.07 | Result verified by repeat analysis | 0 - 0.2 | GI/L | |||||||||
| 101 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 66.6 | Result verified by repeat analysis | 40.5 - 75 | % | |||||||||
| 102 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 23.5 | Result verified by repeat analysis | 15.4 - 48.5 | % | |||||||||
| 103 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 7.2 | Result verified by repeat analysis | 2.6 - 10.1 | % | |||||||||
| 104 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 1.8 | Result verified by repeat analysis | 0 - 6.8 | % | |||||||||
| 105 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 1.0 | Result verified by repeat analysis | 0 - 2 | % | |||||||||
| 106 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 300 | Result verified by repeat analysis | 140 - 400 | GI/L | |||||||||
| 107 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | PA1 EEA-2? | Approved to use EEA-2? | Yes | ||||||||||||
| 108 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | SM01/PLASMA PK TROUGH COLL D/T | Collection Date Predose | Y | 22-Apr-2026 | |||||||||||
| 109 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | SM01/PLASMA PK TROUGH COLL D/T | Collection Time Predose | Y | 09:25 | |||||||||||
| 110 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | SM02/PLASMA PK PEAK COLL D/T | Collection Date Post dose | Y | 22-Apr-2026 | |||||||||||
| 111 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | SM02/PLASMA PK PEAK COLL D/T | Post Dose Collection Time | Y | 10:45 | |||||||||||
| 112 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | SM04/SERUM ADA PRE COLL D/T | Collection Date Predose | Y | 22-Apr-2026 | |||||||||||
| 113 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | SM04/SERUM ADA PRE COLL D/T | Collection Time Predose | Y | 09:25 | |||||||||||
| 114 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | SM09/STOOL PK COLL D/T | Stool Collection Date | Y | 22-Apr-2026 | |||||||||||
| 115 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | SM09/STOOL PK COLL D/T | Stool Collection Time | Y | 05:30 | |||||||||||
| 116 | CZ100122001 | Female | Induction Week 2 | Apr 22, 2026 9:25 AM | 6227697722 | SUBJECT HEIGHT (CM) | Height (cm) | Y | N/A (subject >/= 18 years of age) | cm | ||||||||||
| 117 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | CHEMISTRY PANEL | Total Bilirubin | 5 | 3 - 21 | umol/L | ||||||||||
| 118 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | 1.5 | 0 - 6.2 | umol/L | ||||||||||
| 119 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | CHEMISTRY PANEL | Alkaline Phosphatase | 66 | 35 - 104 | U/L | ||||||||||
| 120 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | CHEMISTRY PANEL | ALT (SGPT) | 25 | 4 - 43 | U/L | ||||||||||
| 121 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | CHEMISTRY PANEL | AST (SGOT) | 24 | 8 - 40 | U/L | ||||||||||
| 122 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | CHEMISTRY PANEL | GGT | 12 | 4 - 49 | U/L | ||||||||||
| 123 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | CHEMISTRY PANEL | LDH | 157 | 53 - 234 | U/L | ||||||||||
| 124 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | CHEMISTRY PANEL | Urea Nitrogen | 3.0 | 1.4 - 8.6 | mmol/L | ||||||||||
| 125 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 51 | 31 - 101 | umol/L | ||||||||||
| 126 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | CHEMISTRY PANEL | Serum Glucose | 4.4 | 3.9 - 5.6 | mmol/L | ||||||||||
| 127 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | CHEMISTRY PANEL | Serum Uric Acid | 258 | 125 - 428 | umol/L | ||||||||||
| 128 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | CHEMISTRY PANEL | Calcium (EDTA) | 2.35 | 2.07 - 2.64 | mmol/L | ||||||||||
| 129 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | CHEMISTRY PANEL | Phosphorus | 0.84 | 0.71 - 1.65 | mmol/L | ||||||||||
| 130 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | CHEMISTRY PANEL | Total Protein | 71 | 61 - 84 | g/L | ||||||||||
| 131 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | CHEMISTRY PANEL | Albumin-BCG | 46 | 33 - 49 | g/L | ||||||||||
| 132 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | CHEMISTRY PANEL | Creatine Kinase | 51 | 26 - 192 | U/L | ||||||||||
| 133 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | CHEMISTRY PANEL | Serum Sodium | 139 | 132 - 147 | mmol/L | ||||||||||
| 134 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | CHEMISTRY PANEL | Serum Potassium | 4.4 | 3.5 - 5.2 | mmol/L | ||||||||||
| 135 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | CHEMISTRY PANEL | Serum Bicarbonate | 23.0 | 19.3 - 29.3 | mmol/L | ||||||||||
| 136 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | CHEMISTRY PANEL | Serum Chloride | 103 | 94 - 112 | mmol/L | ||||||||||
| 137 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | CHEMISTRY PANEL | Magnesium | 0.82 | 0.66 - 1.07 | mmol/L | ||||||||||
| 138 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | CKD-EPI 2021 WITH ADOLESCENTS | CKD-EPI 2021 woRace wAdol -PS | 131 | mL/min/1.73m^2$No Ref Rng | |||||||||||
| 139 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | FECAL COLLECTION D/T | Stool Collection Date | Y | 07-Apr-2026 | |||||||||||
| 140 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | FECAL COLLECTION D/T | Stool Collection Time | Y | 06:00 | |||||||||||
| 141 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 115 | R | L | 116 - 164 | g/L | ||||||||
| 142 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.36 | 0.34 - 0.48 | |||||||||||
| 143 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.5 | 4.1 - 5.6 | TI/L | ||||||||||
| 144 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 25 | R | L | 26 - 34 | pg | ||||||||
| 145 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | |||||||||||
| 146 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 80 | 79 - 98 | fL | ||||||||||
| 147 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 9.11 | 3.8 - 10.7 | GI/L | ||||||||||
| 148 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 6.31 | 1.96 - 7.23 | GI/L | ||||||||||
| 149 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 2.15 | 0.91 - 4.28 | GI/L | ||||||||||
| 150 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.54 | 0.12 - 0.92 | GI/L | ||||||||||
| 151 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.05 | 0 - 0.57 | GI/L | ||||||||||
| 152 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.06 | 0 - 0.2 | GI/L | ||||||||||
| 153 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 69.3 | 40.5 - 75 | % | ||||||||||
| 154 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 23.6 | 15.4 - 48.5 | % | ||||||||||
| 155 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 5.9 | 2.6 - 10.1 | % | ||||||||||
| 156 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 0.5 | 0 - 6.8 | % | ||||||||||
| 157 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.7 | 0 - 2 | % | ||||||||||
| 158 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 386 | 140 - 400 | GI/L | ||||||||||
| 159 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | IS SUBJECT FASTING? | Is Subject Fasting? | Y | Yes | |||||||||||
| 160 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | LIPID PANEL | Direct HDL-C 4th Generation | 1.35 | 1.03 - 1.53 | mmol/L | ||||||||||
| 161 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | LIPID PANEL | Triglycerides (GPO) | 1.11 | 0.41 - 1.63 | mmol/L | ||||||||||
| 162 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | LIPID PANEL | Cholesterol (High Performance) | 4.41 | 3.31 - 5.64 | mmol/L | ||||||||||
| 163 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | LIPID PANEL | LDL Chol Friedewald 4th | 2.55 | 0 - 3.34 | mmol/L | ||||||||||
| 164 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | PA1 EEA-2? | Approved to use EEA-2? | Yes | ||||||||||||
| 165 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | SM01/PLASMA PK TROUGH COLL D/T | Collection Date Predose | Y | 07-Apr-2026 | |||||||||||
| 166 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | SM01/PLASMA PK TROUGH COLL D/T | Collection Time Predose | Y | 11:45 | |||||||||||
| 167 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | SM02/PLASMA PK PEAK COLL D/T | Collection Date Post dose | Y | 07-Apr-2026 | |||||||||||
| 168 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | SM02/PLASMA PK PEAK COLL D/T | Post Dose Collection Time | Y | 13:35 | |||||||||||
| 169 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | SM04/SERUM ADA PRE COLL D/T | Collection Date Predose | Y | 07-Apr-2026 | |||||||||||
| 170 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | SM04/SERUM ADA PRE COLL D/T | Collection Time Predose | Y | 11:45 | |||||||||||
| 171 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | SM10/FECAL BMRKS COLL D/T | Stool Collection Date | Y | 07-Apr-2026 | |||||||||||
| 172 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | SM10/FECAL BMRKS COLL D/T | Stool Collection Time | Y | 06:00 | |||||||||||
| 173 | CZ100122001 | Female | Induction Week 0 | Apr 7, 2026 11:45 AM | 6227697719 | SUBJECT HEIGHT (CM) | Height (cm) | Y | N/A (subject >/= 18 years of age) | cm | ||||||||||
| 174 | CZ100122001 | Female | Biopsy | Mar 23, 2026 12:00 AM | 6227697736 | ANATOMICAL SITE | Anatomical Site | Y | 15 cm | |||||||||||
| 175 | CZ100122001 | Female | Biopsy | Mar 23, 2026 12:00 AM | 6227697736 | BIOPSY COLLECTION METHOD | Collection Method | Y | colonoscopy | |||||||||||
| 176 | CZ100122001 | Female | Biopsy | Mar 23, 2026 12:00 AM | 6227697736 | BIOPSY FIXATIVE USED | Fixative Used | 10% NBF | ||||||||||||
| 177 | CZ100122001 | Female | Biopsy | Mar 23, 2026 12:00 AM | 6227697736 | DATE/TIME PLACED IN FORMALIN | Date Sample placed in Formalin | Y | 23-Mar-2026 | |||||||||||
| 178 | CZ100122001 | Female | Biopsy | Mar 23, 2026 12:00 AM | 6227697736 | DATE/TIME PLACED IN FORMALIN | Time Sample placed in Formalin | Y | 09:42 | |||||||||||
| 179 | CZ100122001 | Female | Biopsy | Mar 23, 2026 12:00 AM | 6227697736 | DIAGNOSIS | Diagnosis: | Y | Ulcerative Colitis | |||||||||||
| 180 | CZ100122001 | Female | Biopsy | Mar 23, 2026 12:00 AM | 6227697736 | INFLAMED AREA | Inflamed area? | Yes | ||||||||||||
| 181 | CZ100122001 | Female | Biopsy | Mar 23, 2026 12:00 AM | 6227697736 | TISSUE BIOPSY EMBEDDING1 | Biopsy technical QC-CL | Smpl meets HT requirements | ||||||||||||
| 182 | CZ100122001 | Female | Biopsy | Mar 23, 2026 12:00 AM | 6227697736 | TISSUE BIOPSY EMBEDDING1 | Biopsy processing Time-CL | 10:00 | ||||||||||||
| 183 | CZ100122001 | Female | Biopsy | Mar 23, 2026 12:00 AM | 6227697736 | TISSUE BIOPSY EMBEDDING1 | Biopsy processing Date-CL | 25-Mar-2026 | ||||||||||||
| 184 | CZ100122001 | Female | Biopsy | Mar 23, 2026 12:00 AM | 6227697736 | TISSUE BIOPSY EMBEDDING1 | Biopsy Comments-CL | Received in 10% NBF | ||||||||||||
| 185 | CZ100122001 | Female | Biopsy | Mar 23, 2026 12:00 AM | 6227697736 | TISSUE BIOPSY EMBEDDING1 | # of Cassettes-(FI)-CL | 1 | ||||||||||||
| 186 | CZ100122001 | Female | Biopsy | Mar 23, 2026 12:00 AM | 6227697736 | ULCERATED AREA | Is biopsy site ulcerated? | Yes | ||||||||||||
| 187 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | CHEMISTRY PANEL | Total Bilirubin | <3 | R | L | Result verified by repeat analysis | 3 - 21 | umol/L | ||||||
| 188 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | CHEMISTRY PANEL | Direct Bilirubin Gen2-Doumas | <1.4 | Result verified by repeat analysis | 0 - 6.2 | umol/L | ||||||||
| 189 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | CHEMISTRY PANEL | Alkaline Phosphatase | 74 | 35 - 104 | U/L | |||||||||
| 190 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | CHEMISTRY PANEL | ALT (SGPT) | 23 | 4 - 43 | U/L | |||||||||
| 191 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | CHEMISTRY PANEL | AST (SGOT) | 23 | 8 - 40 | U/L | |||||||||
| 192 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | CHEMISTRY PANEL | GGT | 9 | 4 - 49 | U/L | |||||||||
| 193 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | CHEMISTRY PANEL | LDH | Test cancelled: Hemolysis-test not performed | |||||||||||
| 194 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | CHEMISTRY PANEL | Urea Nitrogen | 2.5 | 1.4 - 8.6 | mmol/L | |||||||||
| 195 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | CHEMISTRY PANEL | Creatinine(Rate Blanked)-2dp | 55 | 31 - 101 | umol/L | |||||||||
| 196 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | CHEMISTRY PANEL | Serum Glucose | 5.5 | 3.9 - 5.6 | mmol/L | |||||||||
| 197 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | CHEMISTRY PANEL | Serum Uric Acid | 226 | 125 - 428 | umol/L | |||||||||
| 198 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | CHEMISTRY PANEL | Calcium (EDTA) | 2.39 | 2.07 - 2.64 | mmol/L | |||||||||
| 199 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | CHEMISTRY PANEL | Phosphorus | 0.90 | 0.71 - 1.65 | mmol/L | |||||||||
| 200 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | CHEMISTRY PANEL | Total Protein | 73 | 61 - 84 | g/L | |||||||||
| 201 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | CHEMISTRY PANEL | Albumin-BCG | 45 | 33 - 49 | g/L | |||||||||
| 202 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | CHEMISTRY PANEL | Creatine Kinase | 84 | 26 - 192 | U/L | |||||||||
| 203 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | CHEMISTRY PANEL | Serum Sodium | 142 | 132 - 147 | mmol/L | |||||||||
| 204 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | CHEMISTRY PANEL | Serum Potassium | 5.1 | 3.5 - 5.2 | mmol/L | |||||||||
| 205 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | CHEMISTRY PANEL | Serum Bicarbonate | 19.2 | L | 19.3 - 29.3 | mmol/L | ||||||||
| 206 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | CHEMISTRY PANEL | Serum Chloride | 103 | 94 - 112 | mmol/L | |||||||||
| 207 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | CHEMISTRY PANEL | Magnesium | 0.83 | 0.66 - 1.07 | mmol/L | |||||||||
| 208 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | CKD-EPI 2021 WITH ADOLESCENTS | CKD-EPI 2021 woRace wAdol -PS | 129 | mL/min/1.73m^2$No Ref Rng | ||||||||||
| 209 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | FEMALE OF CHILDBEARING POT? | Female/of Childbearing pot.? | Y | Yes | ||||||||||
| 210 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | HBV ELIGIBILITY MET? | HBV Eligibility Criteria Met? | Yes | |||||||||||
| 211 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | HEMATOLOGY&DIFFERENTIAL PANEL | Hemoglobin | 111 | R | L | 116 - 164 | g/L | |||||||
| 212 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | HEMATOLOGY&DIFFERENTIAL PANEL | Hematocrit | 0.36 | 0.34 - 0.48 | ||||||||||
| 213 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC | 4.6 | 4.1 - 5.6 | TI/L | |||||||||
| 214 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | HEMATOLOGY&DIFFERENTIAL PANEL | MCH | 24 | R | L | 26 - 34 | pg | |||||||
| 215 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | HEMATOLOGY&DIFFERENTIAL PANEL | RBC Morphology | No Review Required | NORMOCYTIC;$NORMOCHROMIC | ||||||||||
| 216 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | HEMATOLOGY&DIFFERENTIAL PANEL | MCV | 78 | R | L | 79 - 98 | fL | |||||||
| 217 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | HEMATOLOGY&DIFFERENTIAL PANEL | WBC | 7.66 | 3.8 - 10.7 | GI/L | |||||||||
| 218 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils | 5.37 | 1.96 - 7.23 | GI/L | |||||||||
| 219 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes | 1.63 | 0.91 - 4.28 | GI/L | |||||||||
| 220 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes | 0.55 | 0.12 - 0.92 | GI/L | |||||||||
| 221 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils | 0.08 | 0 - 0.57 | GI/L | |||||||||
| 222 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils | 0.03 | 0 - 0.2 | GI/L | |||||||||
| 223 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | HEMATOLOGY&DIFFERENTIAL PANEL | Neutrophils (%) | 70.2 | 40.5 - 75 | % | |||||||||
| 224 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | HEMATOLOGY&DIFFERENTIAL PANEL | Lymphocytes (%) | 21.2 | 15.4 - 48.5 | % | |||||||||
| 225 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | HEMATOLOGY&DIFFERENTIAL PANEL | Monocytes (%) | 7.2 | 2.6 - 10.1 | % | |||||||||
| 226 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | HEMATOLOGY&DIFFERENTIAL PANEL | Eosinophils (%) | 1.1 | 0 - 6.8 | % | |||||||||
| 227 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | HEMATOLOGY&DIFFERENTIAL PANEL | Basophils (%) | 0.4 | 0 - 2 | % | |||||||||
| 228 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | HEMATOLOGY&DIFFERENTIAL PANEL | Platelets | 412 | R | H | 140 - 400 | GI/L | |||||||
| 229 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | HEPATITIS B CORE AB NON-US | Hepatitis B Core Total | Non-Reactive | Ref Rng:$Non Reactive | ||||||||||
| 230 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | HEPATITIS B SURFACE AB | Anti-HBs II QUAL | Non-Reactive | Ref Rng :$Non Reactive | ||||||||||
| 231 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | HEPATITIS B SURFACE AG NON-US | Hep B Surface AgII | Non-Reactive | Ref Rng:$Non Reactive | ||||||||||
| 232 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | HEPATITIS C VIRUS AB NON-US | Hepatitis C Virus Antibody | Non-Reactive | Ref Rng:$Non Reactive | ||||||||||
| 233 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | HIV 1/2 AG/AB SCREEN | anti-HIV-1/2 antibodies | Non-Reactive | Ref Rng$Non-Reactive | ||||||||||
| 234 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | HIV 1/2 AG/AB SCREEN | HIV -1 p24 antigen | Non-Reactive | Ref Rng$Non-Reactive | ||||||||||
| 235 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | HIV 1/2 AG/AB SCREEN | HIV 1/2 Ag/Ab Screen, Cobas | Non-Reactive | Ref Rng$Non-Reactive | ||||||||||
| 236 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | PA1 EEA-2? | Approved to use EEA-2? | Yes | |||||||||||
| 237 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | QUANTIFERON GOLD MITOGEN/INTER | QFT,TBGoldPlusInt,pl-4-Tubes | Negative | Normal=Negative | ||||||||||
| 238 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | SERUM BETA HCG | B-hCG, Qualitative | Negative | Ref Rng: Negative | ||||||||||
| 239 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | SERUM BETA HCG | B-hCG, Quantitative | <0.6 | Units: mIU/mL$Pre-menopausal$<5.0: Negative$5.0-24.9:Borderline$>/= 25.0: Positive | ||||||||||
| 240 | CZ100122001 | Female | Screening | R | Mar 18, 2026 9:18 AM | 6227697718 | SUBJECT HEIGHT (CM) | Height (cm) | Y | N/A (subject >/= 18 years of age) | cm | |||||||||
| 241 | CZ100122001 | Female | Stool Pathogens | Mar 17, 2026 5:30 PM | 6227697725 | C. DIFF EIA | C. diff GDH Ag,stool-CL | Negative | Ref Rng:Negative | |||||||||||
| 242 | CZ100122001 | Female | Stool Pathogens | Mar 17, 2026 5:30 PM | 6227697725 | C. DIFF EIA | C.diff Toxin A&B,stool-CL | Negative | Ref Rng:Negative |